MedPath

Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens

Conditions
Tuberculosis
Lung Cancer
Registration Number
NCT01322685
Lead Sponsor
Taipei Medical University WanFang Hospital
Brief Summary

The purpose of this study is to study the Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens. Subjects are divided into two groups which are health group and Tuberculosis or lung cancer group in order to compare with the difference.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Health group: between 17 to 90 years old
  • Tuberculosis group: people who are tuberculosis or lung cancer patients and between 17 to 90 years old
Exclusion Criteria
  • Women subjects are before or after the period within two days

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Taipei Medical University - WanFang Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath